hotspot -WSS

hotspot

author：fashion 2025-09-06 02:03:40 - browse：1931

Photo illustration with orange background of Desmond Padhi, PharmD, interim CEO, Latigo (center), with Latigo board chair Nancy Stagliano (left) and Westlake Village BioPartners founding managing director Sean Harper, M.D. (right) -- biotech coverage from STAT — Desmond Padhi, PharmD, interim CEO, Latigo (center), with Latigo board chair Nancy Stagliano (left) and Westlake Village BioPartners founding managing director Sean Harper, M.D. (right) Illustration: Christine Kao/STAT; Courtesy: Steve Shoffner & Michael Haber

After three years being incubated by California VC Westlake Village BioPartners, a new biotech launched Wednesday with $135 million and plans to compete with Vertex Pharmaceuticals.

The startup is called Latigo Biotherapeutics, and it’s launching having already started a Phase 1 trial for a non-opioid pain medicine, LTG-001. The oral therapy is designed to silence pain-signaling neurons by blocking a sodium channel called NaV 1.8.

Westlake had set out years ago to scout out new options for pain medicines, and found a research desert, according to founding managing director Sean Harper. But NaV 1.8 has emerged as a promising option because of its potential to be non-addictive and to lessen pain without affecting a person’s central nervous system, digestion, or heart rate, as opioids can. There were still few high-quality molecules in development that could be licensed from an academic lab or another drug company, so Westlake decided to develop its own.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Medicare slashes safety net hospital payments by nearly $1 billion

WSS

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Scientists grapple with ethics of stem cell research

Heart disease in astronauts blamed on cosmic radiation

Sanders wants to replace patents with prizes for drug inventions

knowledge

hotspot

entertainment

Sports medicine is finally prioritizing gender equality

Are infertility treatments 'essential' during the Covid

Cancer drug shortages should be causing more outrage

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Novavax promises a turnaround & Lilly roils the obesity market

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

United colonoscopy coverage change 'may cost lives,' doctors say

How I helped Pfizer think through the ethics of Viagra

Malaria cases in Florida and Texas: Here’s what you need to know

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

entertainment

Are infertility treatments 'essential' during the Covid

2 officers injured in shooting in Orlando, police say

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

FDA scientists endorse Pfizer/BioNTech Covid

'CMA Fest' 2023: How to watch, who is performing and more

Personalized medicine goes far beyond genetics

hotspot

leisure time

entertainment

hotspot